As of June 16th, 2023, the Vaccine Adverse Events Reporting System (VAERS) had amassed 1,569,668 reports of adverse events linked to COVID-19 vaccinations.
Among these were 35,487 reported deaths, 27,229 cases of myocarditis and pericarditis, and 20,184 incidents of heart attacks, both within the United States and internationally.
Prior to the pandemic, Meissner’s research highlighted that 86% of entries in VAERS were submitted by medical professionals or vaccine manufacturers, with only 14% originating from patients or their families. This distribution underscores VAERS’ effectiveness in signaling myocarditis as a recognized complication of COVID-19 vaccination.
However, deeper insights can be gleaned from autopsies in instances where vaccination is suspected as the cause of death. Walach et al emphasized the necessity of autopsies for all post-vaccination fatalities, to enhance our comprehension of how vaccines might adversely impact the human body. Autopsies stand as a potent diagnostic tool, unraveling the causes of demise and shedding light on the pathophysiological workings of diseases.
COVID-19 vaccines present several avenues of harm to the cardiovascular system, underscored by a substantial number of adverse event reports. This establishes a causal link to fatalities in certain cases.
Conducting autopsies on individuals who passed away post-vaccination, Krauson et al, hailing from the Department of Pathology at Massachusetts General Hospital, Harvard Medical School, carried out a limited number of investigations.
They detected mRNA from the COVID-19 vaccines in human heart tissue up to a span of 30 days. However, determining how long the synthetic genetic code lingers in the heart proved inconclusive due to insufficient sample size.
Regrettably, Krauson’s stain for the Spike protein produced “nonspecific” outcomes. Yet, when properly stained as demonstrated by Baumeier et al, it is expected that Krauson would have indeed revealed Spike protein in close proximity to mRNA, as the genetic code persists in producing the hazardous protein and inducing inflammation, as depicted in the slide above.
Based on factors like the quantity of mRNA in the injection, time elapsed, and potentially individual susceptibilities (such as an athletic heart or cardiomyopathy), it is conceivable that some individuals may have remnants of the COVID-19 vaccine in their heart tissue.
The long-term ramifications for cardiac events, heart failure, and related issues remain uncertain. Despite attempts within the academic community to downplay Krauson et al’s findings, this study does not bode well for the Bio-Pharmaceutical Complex.